PusledSelect PFA Registry - Trial NCT06393920
Access comprehensive clinical trial information for NCT06393920 through Pure Global AI's free database. This phase not specified trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 400 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Medtronic Cardiac Rhythm and Heart Failure
Timeline & Enrollment
N/A
Jul 01, 2024
Oct 01, 2029
Primary Outcome
Freedom from Atrial Fibrillation
Summary
PulsedSelect is a prospective, global, multi-center, observational post-approval study.
 Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06393920
Non-Device Trial